These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9164651)
1. Molecular regulation of cellular invasion--role of gelatinase A and TIMP-2. Yu AE; Hewitt RE; Kleiner DE; Stetler-Stevenson WG Biochem Cell Biol; 1996; 74(6):823-31. PubMed ID: 9164651 [TBL] [Abstract][Full Text] [Related]
2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
4. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Fridman R; Toth M; Peña D; Mobashery S Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Alexander CM; Hansell EJ; Behrendtsen O; Flannery ML; Kishnani NS; Hawkes SP; Werb Z Development; 1996 Jun; 122(6):1723-36. PubMed ID: 8674412 [TBL] [Abstract][Full Text] [Related]
6. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071 [TBL] [Abstract][Full Text] [Related]
7. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650 [TBL] [Abstract][Full Text] [Related]
8. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Sato H; Okada Y; Seiki M Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203 [TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation. Teesalu T; Masson R; Basset P; Blasi F; Talarico D Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695 [TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
12. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596 [TBL] [Abstract][Full Text] [Related]
14. Membrane-type metalloproteinases in tumor invasion. Polette M; Birembaut P Int J Biochem Cell Biol; 1998 Nov; 30(11):1195-202. PubMed ID: 9839445 [TBL] [Abstract][Full Text] [Related]
15. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [TBL] [Abstract][Full Text] [Related]
16. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
18. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503 [TBL] [Abstract][Full Text] [Related]
19. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Ward RV; Hembry RM; Reynolds JJ; Murphy G Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113 [TBL] [Abstract][Full Text] [Related]
20. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Tanney DC; Feng L; Pollock AS; Lovett DH Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]